Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share (NASDAQ:OACC) — Market Cap & Net Worth
Market Cap & Net Worth: Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share (OACC)
Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share (NASDAQ:OACC) has a market capitalization of $213.26 Million ($213.26 Million) as of September 26, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #16404 globally and #3890 in its home market, demonstrating a 0.08% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share's stock price $10.78 by its total outstanding shares 19783010 (19.78 Million). Also see Oaktree Acquisition Corp. III Life Scien asset portfolio for a full breakdown of the balance sheet.
Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share Market Cap History: 2025 to 2026
Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share's market capitalization history from 2025 to 2026. Data shows growth from $209.30 Million to $213.26 Million (4.76% CAGR). Also see cash efficiency ratio of Oaktree Acquisition Corp. III Life Scien for how efficiently the company converts equity into cash flow.
Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check Oaktree Acquisition Corp. III Life Scien share price for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of OACC by Market Capitalization
Companies near Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share in the global market cap rankings as of September 26, 2026. Review OACC tangible net worth ratio to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share by market ranking:
- Twenty One Capital, Inc. (NYSE:XXI): Ranked #5691 globally with a market cap of $2.30 Billion USD.
- Drugs Made In America Acquisition II Corp. Ordinary Shares (NASDAQ:DMII): Ranked #11047 globally with a market cap of $647.19 Million USD.
- Ares Acquisition Corporation II (NYSE:AACT): Ranked #11511 globally with a market cap of $587.05 Million USD.
- Voyager Acquisition Corp (NASDAQ:VACH): Ranked #11927 globally with a market cap of $541.25 Million USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #5691 | Twenty One Capital, Inc. | NYSE:XXI | $2.30 Billion | $6.64 |
| #11047 | Drugs Made In America Acquisition II Corp. Ordinary Shares | NASDAQ:DMII | $647.19 Million | $10.16 |
| #11511 | Ares Acquisition Corporation II | NYSE:AACT | $587.05 Million | $9.49 |
| #11927 | Voyager Acquisition Corp | NASDAQ:VACH | $541.25 Million | $24.79 |
Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share Historical Marketcap From 2025 to 2026
Between 2025 and today, Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share's market cap moved from $209.30 Million to $ 213.26 Million, with a yearly change of 4.76%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $213.26 Million | +1.89% |
| 2025 | $209.30 Million | -- |
End of Day Market Cap According to Different Sources
On Sep 26th, 2026 the market cap of Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $213.26 Million USD |
| MoneyControl | $213.26 Million USD |
| MarketWatch | $213.26 Million USD |
| marketcap.company | $213.26 Million USD |
| Reuters | $213.26 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share
Oaktree Acquisition Corp. III Life Sciences does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. It intends to target companies in the biopharmaceutical, medical devices, diagnostics, and specialized healthcare services sectors in … Read more